|
|
Office Locations:
|
1350 Old Bayshore Hwy, Suite 520
Burlingame, CA 94010
| | |
|
|
|
|
|
|
|
Sonder Capital, based in Silicon Valley, invests in early stage medical technology startups. The group has experience as founders, corporate, venture capital and hedge fund investors. The Sonder Capital team takes a craftsman-like approach to helping startups positively impact healthcare systems worldwide. The firm prefers firms with significant impact on patient outcomes, access to care or business model, often supported by the opportunity for a $1B+ market cap. Sonder Capital primarily sources investment opportunities through its network and via referrals.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
